Ticagrelor With Low-dose Versus Regular Aspirin in Patients With Acute Coronary Syndrome (ACS) at High-Risk for Ischemia After Percutaneous Coronary Intervention
A phase 4 trial registered on ClinicalTrials.gov. The registry status is recruiting. It plans to enroll 1220 participants.
Also called NCT04240834
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; single masking; primary purpose treatment
- Phase
- Phase 4
- Enrolled
- 1,220 participants
- Registry
-
NCT04240834
-
- Started
- (actual)
- Primary completion
- (anticipated)
- Completion
- (anticipated)
- Countries
- China
- Registry status
- Recruiting
Technical summary
Registry record NCT04240834. Randomized; single masking; primary purpose treatment. Start 2021-02-01 (actual); primary completion 2025-12 (anticipated). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Ticagrelor With Low-dose Versus Regular Aspirin in Patients With Acute Coronary Syndrome (ACS) at High-Risk for Ischemia After Percutaneous Coronary Intervention
- Acronym
- LD-ASPIRIN
- Condition
- Acute Coronary Syndrome
- Condition
- Interventional Cardiology
- Intervention (Drug)
- Aspirin
- Intervention (Drug)
- Ticagrelor
- Lead sponsor
- Fu Wai Hospital, Beijing, China
Record details
- Record id
cardio:ct-nct04240834- Content hash
0d2b802a785c31bcb1b6ffa10f5289439a8a4b406a6e732bcf234513f0b3a8df